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Abstract
Background: Patients often experience changes or transitions in where and by whom they are
cared for at the end of life. These cause stress for both patients and families. Although not all
transitions during the end of life can be avoided, advance identification of those who could
potentially experience numerous transitions may allow providers and caregivers to anticipate the
problem and consider strategies to minimize their occurrence. This study examines the
relationship between patient characteristics and the total number of transitions experienced by the
patient from the date of admission to a palliative care program (PCP) to death and during final
weeks of life.
Methods: Subjects included all adults registered with the PCP in Halifax, Nova Scotia, Canada
between 1998 and 2002 and who had died during that period. Data was extracted from the regional
PCP database and linked to census information. Transitions were defined as either: 1) a change in
location of where the patient was cared for; or 2) a change in which service (specialist groupings,
primary care, etc) provided care. Descriptive statistics were calculated plus rate ratios for the
association between patient characteristics and total number of transitions.
Results: In total, 3972 patients made 5903 transitions during the study period. Although 28%
experienced no transitions, over 40% experienced one and 6.3% five or more. At least one
transition was made by 47% during the last four weeks of life. Adjusted results suggest women, the
elderly and more recent death are associated with experiencing fewer transitions. Multiple
transitions were associated with a hospital death and a cancer diagnosis. During the last month of
life, age was no longer associated with the total number of transitions, cancer patients were found
to experience a similar number or fewer transitions than patients with a non-cancer diagnosis and
pain and symptom control become a significant factor associated with a greater number of
transitions.
Conclusion: Our data suggest there is some variation in the number of transitions associated with
the demographics and diagnoses of patients. Associations with gender and age require further
exploration as does the contribution of caregiver supports and symptom issues.
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Background
During the end of life patients often experience changes or
transitions in where and by whom they are cared for.
These situations may result in increased anxiety for both
the patient and their caregivers [1]. Such transitions may
involve a change in hospital wards, a move from hospital
to home or long-term care facility or a change in health
care provider. With each transition there is a need for
planned and integrated transfer of patient information,
both medical and personal, the reiteration of patient pref-
erences and the renegotiation of care goals. Transitions
also require the patient and their caregivers to create new
or redefined relationships with an expanding set of health
care providers, establish new communication channels
and form new trusts [2]. Physical aspects of a transition
also need to be addressed and implemented in a timely
and coordinated matter in order to minimize the effect on
the patient and their caregiver's experience of care. These
include the provision of hospital equipment in the home
or advanced planning for admission/transfer to an alter-
native ward or institution.
At the same time we acknowledge that transitions may
also be quite welcomed by patients and families. When
the stress of symptoms or caregiving situations is too
much at home, a move to hospital may be a relief to all.
The same may be true of a transition of service provider
such that patients may see the most competent profes-
sionals needed are finally involved in their care.
Nevertheless, in our modern health care systems we must
ensure that care that moves patients across care settings
and across clinical programs is as integrated and as
smooth as possible. Although not all transitions during
the end of life can be avoided, reducing the number of
unnecessary changes in settings and providers may allevi-
ate some hazards associated with transitions and provide
the patient and their caregiver with a better care experi-
ence and quality of life during the end of life.
The database maintained by the Palliative Care Program
(PCP) at the Queen Elizabeth II Health Sciences Center
(QEII) in Halifax, Nova Scotia, Canada provides us with a
relatively unique opportunity to track how often and
when transitions are experienced by patients admitted to
the program in addition to the provision of some basic
patient demographic information. The PCP is comprised
of an in-patient acute care unit, an in-hospital consulta-
tion service and offers home consultation services and an
oncology outpatient clinic consultation service. Team
members include health care professionals such as physi-
cians, nurses and pharmacists in addition to social work-
ers, spiritual care providers and volunteers. Since opening
in 1988, the PCP has experienced major gains in the pro-
portion of advanced cancer patients within the Halifax
Regional Municipality (population approximately
350,000) being admitted into the program, increasing
from 21% of all those who died of cancer in 1988 to 62%
by 1997 [3,4]. Once admitted to the PCP, changes or tran-
sitions in location and care provided to patients are docu-
mented on the program's electronic database [5].
By looking at the relationship between number of transi-
tions and patient characteristics we hope to identify
patient predictors of multiple transitions. Advance identi-
fication of those who could potentially experience numer-
ous transitions will allow providers and caregivers to
anticipate the problem and consider strategies to mini-
mize their occurrence. Advance identification will also
allow the patient and caregiver to prepare for these transi-
tions, both physically and emotionally, before they occur.
In a companion paper we described the distribution of
transitions in care experienced by palliative care patients
during the time subsequent to admission to a comprehen-
sive palliative care program [6]. In this paper we describe
the relationship between patient characteristics and the
total number of transitions experienced by the patient
from the date of admission to the PCP to death and dur-
ing the final two and four weeks of life.
Methods
This study represents a further investigation of transitions
experienced by all patients registered in a comprehensive
palliative care program (PCP) at the Queen Elizabeth II
Health Services Center (QEII) in Halifax, Nova Scotia,
Canada between January 1, 1998 and December 31, 2002
with a recorded date of death on or prior to December 31,
2002. Details of the initial investigation describing the
distribution of transitions in care among these patients
have been previously published [6].
The research ethics board of the Nova Scotia Capital Dis-
trict Health Authority, Halifax, Nova Scotia provided eth-
ical approval for this research. Personal identifying
information was not included on the records used for this
project. All patient information available was provided
anonymously to preserve confidentiality.
Data
Data for this study were obtained from the QEII PCP data-
base, augmented with aggregate Statistics Canada Census
(2001) information. During the five year study period,
4434 patients were admitted to the program; 90% with a
cancer diagnosis. The number of patients admitted to the
program each year remained relatively stable (mean, 887;
standard deviation [SD] 38). Information contained
within the PCP database is considered to be valid and reli-
able. Data are entered by a trained entry clerk who is ded-
icated to ensure the completeness and accuracy of allBMC Palliative Care 2006, 5:4 http://www.biomedcentral.com/1472-684X/5/4
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information. The data entry program contains a number
of checks to reduce the incidence of missing and incorrect
information. For instance, where feasible, new informa-
tion is automatically validated against existing data, fields
are made mandatory to force data entry and formats
forced for particular fields. In addition, a series of reports
are generated at regular intervals identifying what infor-
mation is missing. Collection of this missing information
is immediately sought to complete the record; hence few
records include missing data.
For each subject, demographic information (gender, date
of birth, date of death, postal code), diagnoses, caregiver
relationship (for example, spouse, daughter, son, friend),
primary reason for referral (pain, other symptom manage-
ment, patient or family support, staff support, home con-
sultation), location of death and program transition data
were extracted from the PCP database. For each transition,
the date, location of care (for example, home, acute care,
long-term care) and an indicator of the services provided
were included. These services could involve inpatient hos-
pital care in the Palliative Care Unit, medical or surgical
services from other acute inpatient care units, outpatient
care provided by the Nova Scotia Cancer Center (NSCC)
PCP clinic, PCP Home Support Service, care in a long-
term care facility or care by a family physician.
Because individual level income information was not
available from the PCP database, an aggregate measure of
income derived from census information and grouped by
enumeration area or 'neighbourhood' was employed.
These 'neighbourhood income quintiles' were linked to
the PCP database information via the postal code. Simi-
larly, a geographical indicator of urban or rural residency,
based on population density, was also generated and
linked to the file. Prior to data linkage and release of the
data for analysis, all personal identifying information was
removed.
Measures
We define a transition as either: 1) a change in location of
where the patient was cared for by the PCP; or 2) a change
in which service provided care. For example, a transition
may be a move to or from the home, a specific acute care
unit or a long-term care facility. A transition would also
occur if the patient stayed in a single location, for example
at home, but the care being provided is transferred from
PCP staff (active care by PCP staff) to NSCC staff doctors
(without PCP involvement), or to their family physician
or home care nurse (non-active, no longer cared for by
PCP staff) or vice versa. This change in service provider or
'transfer of care' transition scenario is illustrated below:
Home → Home
(Active: care by PCP staff) → (Non-active: care by family
physician)
Each patient's diagnosis was categorized within one of six
cancer groupings or as having problems other than cancer
such as circulatory or respiratory disease. Site specific can-
cer groupings included the lung, colorectal, female breast,
prostate, lymphatic and hematopietic tissue and all other
cancers. Four locations of death were defined: in the hos-
pital (excluding the inpatient PCP unit), within the inpa-
tient PCP unit, at home and death occurring within a
long-term care facility. Because the total time a patient was
enrolled in the PCP varied, a 'survival' variable was created
which was defined as the number of days between date of
the initial admission to the PCP and death.
Analysis
The total number and location of transitions experienced
by patients from their initial admission to the PCP and
during the final two and four weeks of life period were
counted and summary statistics provided. Next, patient
characteristics were examined, categorized and descriptive
statistics presented.
Due to the highly skewed distribution of the total number
of transitions experienced by patients admitted to the
PCP, negative binomial regression was used to examine
the association between total transitions and patient char-
acteristics. To account for the variation in length of sur-
vival time, the time between each patient's date of
enrollment and death, the log of survival was incorpo-
rated as an 'offset' in each regression model. Univariate or
unadjusted regression analysis was followed by multivar-
iate regression where patient characteristics found to be
significantly associated with the total number of transi-
tions, at the 0.05 level of significance in the unadjusted
analysis were included in the initial model. Manual back-
wards elimination methods were then used to develop the
most parsimonious model of total number of transitions
and patient characteristics. All patient characteristics
retained in the final multivariate model were significant at
the 0.05 level. Regression coefficients are exponentiated
and reported as rate ratios (RR). Similarly, the association
between patient characteristics and the number of transi-
tions occurring within the four and two week periods
prior to death was examined. All analyses were conducted
using SAS software [7].
Results
Between January 1, 1998 and December 31, 2002, 3972
adult patients were admitted to the QEII PCP and had
died on or prior to December 31, 2002. Just over half were
male (52%), 65% were 65 years of age or older (mean
68.5 years, SD 13.7), the majority lived in an urban setting
(70%) and 90% had been diagnosed with cancer. TheBMC Palliative Care 2006, 5:4 http://www.biomedcentral.com/1472-684X/5/4
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major single cancer site was the lung accounting for 29%
of all cancer diagnoses. The primary reason recorded for
admission to the PCP was pain (46%), followed by the
need for patient or family support (23%) and need for
other symptom control (22%). Overall, just over half of
patients admitted to the PCP (51%) experienced a hospi-
tal death outside the inpatient PCP unit whereas 31% died
in their home. However, home deaths among PCP
patients who had received at least one home visit by the
PCP team, was found to be much higher, at 58.5%. Sur-
vival time, the number of days between program admis-
sion and death, varied from 0 days (died same day as
admitted to the PCP) to 1688 days, with a mean of 100.6
(SD 163.2) and median of 45 days. Eighty five percent of
patients admitted to the PCP survived 6 months or less. A
table of relevant patient characteristics may be found in a
previously published article [6].
In total, 5903 transitions were experienced by PCP
patients over the five year study period (mean 1.5, SD 1.8;
median 1; range 0 – 21). Twenty eight percent did not
experience a transition following admission to the PCP,
an indication that this group of patients experienced no
change in the care provided or the location of care from
the point of PCP admission to death. Over 40% experi-
enced one transition while only 6.3% of PCP patients
experienced five or more transitions. During the last four
and two weeks of life, 47% and 36% of patients, respec-
tively, experienced at least one transition. The mean
number of transitions among patients during the last four
weeks (mean 0.6, SD 0.8; median 0; range 0–6) and last
two weeks (mean 0.4, SD 0.6; median 0; range 0–4) prior
to death proved less than one. Further information per-
taining to the number and type of transitions experienced
by PCP patients are detailed as part of an alternate article
by the authors [6].
Results from the examination of the association between
patient characteristics and the total number of transitions
experienced using regression techniques are illustrated in
Table 1. After accounting for all other characteristics
retained in the final multivariate model, fewer transitions
were associated with being female (adjusted rate ratio
[RR] 0.91; 95% confidence interval [CI] 0.84, 0.99),
increasing age (for patients aged 85+ years compared to
those <65 years, adjusted RR 0.81; 95%CI 0.69, 0.95),
dying in a long term care facility compared to home
(adjusted RR 0.78; 95%CI 0.62, 0.97) and over time (e.g.
compared to 1998, for deaths in 2002, adjusted RR 0.73;
95%CI 0.65, 0.83). A greater number of transitions were
associated with death in hospital, both in the PCP inpa-
tient unit and other acute care units. Patients dying in the
PCP inpatient unit experienced 118% more transitions
than patients who died at home (adjusted RR 2.18;
95%CI 1.97, 2.42) whereas patients dying in other hospi-
tal acute care units experienced 19% more (adjusted RR
1.19; 95%CI 1.09, 1.31). Compared to patients who did
not have a cancer diagnosis, a greater number of transi-
tions were experienced by those dying with cancer of the
lung (adjusted RR 1.29; 95%CI 1.06, 1.58), lymphatic
and hematopoietic tissue cancers (adjusted RR 1.39;
95%CI 1.09, 1.77) and all other cancer sites combined
(adjusted RR 1.22; 95%CI 1.01, 1.47). The number of
transitions among patients with colorectal cancer, female
breast cancer and prostate cancer did not differ signifi-
cantly from patients who were dying from disease other
than cancer. Although significantly associated with the
total number of transitions in the unadjusted analysis, the
relationship of the primary caregiver to the patient was no
longer a significant factor following multivariate adjust-
ments. Urban or rural residency, neighbourhood income
quintile and the primary reason for referral to the PCP
were not significantly associated with the total number of
transitions from time of program admission to death, in
the unadjusted or final multivariate regression models.
During the last four and two weeks of life, sex, diagnoses,
location of death and year of death but not age, remained
significantly associated with the number of transitions
during the time period (Table 2). Also significantly associ-
ated with the total number of transitions during the two
and four week periods prior to death was the primary rea-
son for referral to the PCP. During these final weeks of life
a greater number of transitions was associated with
patients citing pain (at four weeks, adjusted RR 1.38;
95%CI 1.04, 1.82; at two weeks, adjusted RR 1.46; 95%CI
1.06, 2.01) and symptom control (at four weeks, adjusted
RR 1.52; 95%CI 1.13, 2.06; at two weeks, adjusted RR
1.56; 95%CI 1.11, 2.20) as reasons for referral to the PCP
compared to the need for a home consultation. As death
drew nearer, patients who died in the PCP unit and those
in other hospital wards tended to experience more transi-
tions. For instance, during the four and two week period
prior to death, patients dying in the PCP unit had more
transitions than those who died at home (within four
weeks prior to death, adjusted RR 2.98; 95%CI 2.45, 3.62;
within two weeks prior to death, adjusted RR 4.09; 95%CI
3.26, 5.13). During these final weeks of life patients diag-
nosed with female breast (adjusted RR 0.53; 95%CI 0.34,
0.82), prostate (adjusted RR 0.38; 95%CI 0.23, 0.61) and
colorectal cancers (adjusted RR 0.66; 95%CI 0.44, 0.99)
were all found to experience fewer transitions than PCP
patients who did not have a cancer diagnosis. This result
differs from that estimated during the time period from
initial PCP admission to death where no differences were
found. In contrast, although experiencing significantly
more transitions in the period spanning from initial PCP
admission to death, patients with cancer of the lung, lym-
phatic and hematopoietic tissue and all other sites experi-BMC Palliative Care 2006, 5:4 http://www.biomedcentral.com/1472-684X/5/4
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Table 1: The association of patient characteristics to the total number of transitions
Characteristic Rate Ratio (RR)
Unadjusted (95% CI) Adjusted* (95% CI)
Gender (vs male)
Female 0.86 (0.80, 0.94) 0.91 (0.84, 0.99)
Age (vs <65 years)
65–74 0.84 (0.76, 0.93) 0.86 (0.78, 0.95)
75–84 0.74 (0.67, 0.82) 0.82 (0.74, 0.90)
85+ 0.69 (0.59, 0.81) 0.81 (0.69, 0.95)
Location of death (vs home)
Inpatient PCP unit 2.17 (1.95, 2.42) 2.18 (1.97, 2.42)
Hospital 1.23 (1.12, 1.35) 1.19 (1.09, 1.31)
Long term care 0.70 (0.55, 0.88) 0.78 (0.62, 0.97)
Year of death (vs 1998)
1999 0.81 (0.71, 0.93) 0.77 (0.68, 0.88)
2000 0.86 (0.76, 0.99) 0.77 (0.67, 0.87)
2001 0.75 (0.65, 0.86) 0.69 (0.60, 0.78)
2002 0.82 (0.71, 0.94) 0.73 (0.64, 0.83)
Diagnoses (vs other disease, no cancer)
Lung cancer 1.54 (1.28, 1.86) 1.29 (1.06, 1.58)
Colorectal 1.26 (1.02, 1.55) 1.08 (0.88, 1.33)
Female breast 1.09 (0.86, 1.35) 0.91 (0.73, 1.14)
Prostate 1.12 (0.88, 1.43) 1.00 (0.79, 1.27)
Lymphatic & hematopoietic tissue 1.49 (1.16, 1.90) 1.39 (1.09, 1.77)
All other cancers 1.43 (1.19, 1.72) 1.22 (1.01, 1.47)
Census residency indicator (vs urban)
Urban 0.95 (0.86, 1.03) -
Neighbourhood income quintile (vs upper 
middle)
Low 1.07 (0.94, 1.22) -
Lower middle 1.04 (0.91, 1.19)
Middle 1.01 (0.88, 1.14)
Upper 1.04 (0.91, 1.18)
Caregiver relationship (vs spouse/partner)
Child 0.85 (0.77, 0.94) -
Parents/other relations 1.08 (0.96, 1.22)
Other 0.94 (0.74, 1.19)
Primary reason for referral to PCP (vs 
home consultation)
Pain 0.93 (0.84, 1.11) -
Other symptom control 0.85 (0.73, 0.99)
Patient or family support 0.90 (0.78, 1.05)
Staff support 0.94 (0.71, 1.25)
* Controlled for all other variables in the model. The census residency indicator, neighbourhood income quintile, relationship of the primary 
caregiver and the primary reason for referral to the PCP were not significantly associated with the total number of transitions in the final 
multivariate regression model.
Notes: 1. The log number of days between date of PCP admission and death for each patient was accounted for in the regression as the 'offset'.
2. The regression coefficients were exponentiated to express effects as rate ratios.BMC Palliative Care 2006, 5:4 http://www.biomedcentral.com/1472-684X/5/4
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enced a similar number of transitions as those with other
disease during the final four and two weeks of life.
Table 3 provides a summary of patient characteristics
found to be significantly associated with total transitions
within each time period prior to death.
Discussion
Overall, results suggest PCP patients who experienced a
hospital death and those with a cancer diagnosis were
more likely to undergo multiple transitions during the
time period from initial PCP admission to death. Fewer
transitions were associated with being female, elderly and
having died more recently. In focusing on the last month
of life, these associations change somewhat with age no
longer being associated with the total number of transi-
tions, some cancer diagnoses being similar to or related to
fewer transitions than a non-cancer diagnosis, and pain
and symptom control becoming a significant factor asso-
ciated with a greater number of transitions.
During the time period from initial PCP admission to
death, patients dying in the PCP inpatient unit were found
to have twice as many transitions compared to those who
died at home. Further, the number of transitions during
the last two weeks of life was found to be four times
higher among patients with a PCP inpatient death com-
pared to a home death. Anecdotal evidence gained from
clinical experience suggests patients admitted to the PCP
inpatient unit have more 'complicated' needs with respect
to pain, symptom control and psychosocial issues.
Because of this, they tend to be readmitted to the unit fol-
lowing transitions elsewhere. Our data provide some evi-
dence to support this view. During the last four and two
weeks of life, pain and other symptom control as reasons
for PCP referral were found to be significant factors asso-
ciated with greater total transitions suggesting patients in
the PCP inpatient unit and other acute care hospital wards
are more in need of this form of care. However, even after
adjustments are made for these pain and symptom fac-
tors, a clear association remains between having had mul-
Table 2: The association of patient characteristics to the total number of transitions during the last two and four weeks of life
Characteristic Adjusted* Rate Ratio (RR) (95% CI)
Four weeks prior to death Two weeks prior to death
Gender (vs male)
Female 0.77 (0.66, 0.89) 0.69 (0.58, 0.82)
Location of death (vs home)
Inpatient PCP unit 2.98 (2.45, 3.62) 4.09 (3.26, 5.13)
Hospital 1.46 (1.23, 1.72) 1.94 (1.59, 2.37)
Long term care 0.39 (0.24, 0.64) 0.54 (0.31, 0.92)
Year of death (vs 1998)
1999 0.60 (0.48, 0.76) 0.54 (0.41, 0.70)
2000 0.72 (0.57, 0.90) 0.69 (0.53, 0.89)
2001 0.58 (0.46, 0.73) 0.57 (0.44, 0.75)
2002 0.69 (0.54, 0.87) 0.60 (0.46, 0.79)
Diagnoses (vs other disease, no cancer)
Lung cancer 0.97 (0.71, 1.33) 0.87 (0.61, 1.25)
Colorectal 0.68 (0.48, 0.97) 0.66 (0.44, 0.99)
Female breast 0.57 (0.39, 0.84) 0.53 (0.34, 0.82)
Prostate 0.45 (0.29, 0.69) 0.38 (0.23, 0.61)
Lymphatic & hematopoietic tissue 1.08 (0.72, 1.62) 1.01 (0.63, 1.62)
All other cancers 0.89 (0.65, 1.21) 0.75 (0.52, 1.06)
Primary reason for referral to PCP (vs 
home consultation)
Pain 1.38 (1.04, 1.82) 1.46 (1.06, 2.01)
Other symptom control 1.52 (1.13, 2.06) 1.56 (1.11, 2.20)
Patient or family support 1.21 (0.90, 1.62) 1.18 (0.84, 1.66)
Staff support 1.49 (0.90, 2.49) 1.26 (0.69, 2.28)
* Controlled for all other variables in model. Age, the census residency indicator, neighbourhood income quintile and relationship of the primary 
caregiver were not significantly associated with the total number of transitions in the final multivariate regression model.
Notes: 1. The log number of days between date of PCP admission and death for each patient was accounted for in the regression as the 'offset'.
2. The regression coefficients were exponentiated to express effects as rate ratios.BMC Palliative Care 2006, 5:4 http://www.biomedcentral.com/1472-684X/5/4
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tiple transitions and dying in the PCP inpatient unit. We
suggest that once a relationship and a comfort level
between patient and the PCP unit staff becomes estab-
lished, the patient is more inclined to return to the PCP
unit as death draws near.
Over the full time period from PCP admission to death
(Table 1), patients referred to the PCP with cancer experi-
enced significantly more transitions than the subset of
referred patients without a cancer diagnosis. However, as
death drew near (Table 2, last four and two weeks of life)
this situation reversed and cancer patients experienced
fewer transitions than non cancer patients. In the early
phase of the move toward palliating cancer patients,
oncological therapies and potential complications may
necessitate more transitions in care. In general, cancer has
a longer time course with a much slower and predictable
decline allowing services to be organized more easily in
Table 3: Summary of patient characteristics found to be significantly associated with total transitions by time period prior to death
Association of predictor to total transitions*
Time periods when transitions experienced




5903 (1.5, SD 1.8) 2446 (0.6, SD 0.8) 1654 (0.4, SD 0.6)
Effect of patient characteristic 
on total transitions
Gender (vs male)
Female gender associated with 
fewer transitions
Age (vs < 65 years)
Older age associated with 
fewer transitions
Location of death (vs home)
Death occurring in the inpatient 
PCP unit or acute hospital 
setting associated with more 
transitions
Death occurring in a long term 
care facility associated with 
fewer transitions
Year of death (vs 1998)
Patients dying between 1999 
and 2002 associated with fewer 
transitions
Diagnoses (vs other disease, no 
cancer)
A cancer diagnosis associated 
with more transitions
A cancer diagnosis associated 
with fewer transitions
Primary reason for referral to 
PCP (vs home consultation)
Referral for pain or other 
symptom control associated 
with more transitions
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the longer timeline available. Cancer patients often have
clearer goals of care and end points. However, non cancer
patients have more uncertainty of when they will die.
Because there may be reversible mechanisms causing their
decline and potential treatments available, the time when
palliation is needed may be more difficult to define. A
good example of this is congestive heart failure.
Women admitted to the PCP experienced fewer transi-
tions than men during their total time in the program fol-
lowing adjustments for the effects of age, diagnosis, year
of death and location of death. A reduced number of tran-
sitions among women is even more apparent during the
last four and two weeks of life. Why would women make
fewer transitions? Do women have different goals in
where and how they are cared for during the end of life? Is
a home death more desirable among women or does their
disease progression and need for support differ from
men? Closer examination of our data indicates a small,
statistically insignificant difference in the number of
home deaths among men and women who had been pro-
vided care at home at least once while a patient of the PCP
(for women 51.4%; men 48.6%). Previous studies we
conducted demonstrate that women with breast cancer
are more likely to die out of hospital than women with
other cancers and men in general [8]. An alternate view
might also consider fewer transitions the result of
women's needs during the end of life being overlooked by
the health care system, in that they are not getting access
to needed hospital or community services. Finally, we
wonder if caregiver availability and ability to women
might be different than for men? Each of these questions
deserves further study in order to understand whether or
not women have different needs necessitating fewer tran-
sitions or are being denied access to some elements of
care.
Age was also a factor in the number of transitions a PCP
patient may experience. After accounting for gender, diag-
noses, year of death and location of death, fewer transi-
tions were evident with increasing age. This association
was evident only during the full time period from pro-
gram admission to death and not a significant indicator
during the last four or two weeks of life. Is this reflective
of new developments in palliative care and chemotherapy
regimens being given among younger patients, particu-
larly when they are first admitted to the PCP? There is evi-
dence that the elderly have less access to screening and
state of the art treatment for cancer [9-11]. Or do younger
patients have more aggressive disease demanding greater
symptom control? Alternatively, it may be that older
patients are already in hospital, home or long term care
and inclined to stay in that situation.
Compared to the initial study year, 1998, the number of
transitions among PCP patients in subsequent years has
declined significantly. This reduction could be a reflection
of more community services being available such as the
expansion of home care [12] allowing people to stay at
home when they might have otherwise needed hospitali-
zation. The countering argument is that fewer hospital
supports, most notably fewer acute hospital beds, are
available in the more recent years of the study perhaps
making transition to hospital less likely [13].
Although the number of beds available in the inpatient
unit of the PCP has remained stable since 1997, the reduc-
tion in the number of transitions made by patients from
1999 onward may be a reflection of an increase in the
number of Home Consult Registered Nurses (RN) associ-
ated with the program. In 1999 the number of home con-
sult RNs rose from three to five.
The demographics of the adult patients admitted to the
QEII Health Sciences Center PCP have changed slightly
since program initiation in 1988 [3]. Compared to the
1988 to 1993 period, the number of males involved in the
program declined by only 2% (from 54% in 1988–1993
to 52% 1998–2002), while the median number of sur-
vival days, the time from admission to the PCP to death,
decreased from 54 days in 1988–1993 to 45 days in
1998–2002. This latter change reduces the number of sur-
vival days available to patients for transitions and demon-
strates the need for our "survival time" adjustment. A
reduction in the median number of days in the PCP may
be an indication of less time available to affect planned,
coordinated and integrated care in a way that might min-
imize transitions for patients. Alternatively, the reduction
may be a reflection of changes in oncological practice for
palliative regimes over the time period.
Although slightly more non cancer patients were admitted
to the PCP in later years, cancer patients continue to con-
stitute the majority of PCP admissions, in particular
patients with cancer of the lung. Cancer of the lung per-
sists as the most common site of cancer mortality in Can-
ada with deaths in Nova Scotia being higher than the
national average [14]. It is therefore reasonable to expect
a greater percentage of lung cancer patients being admit-
ted to the PCP. Our lung cancer patients represented 26%
of all PCP patients, a slightly higher proportion than that
reported in Ontario (20%) and United Kingdom (23%)
palliative care settings [15,16]. Even though the propor-BMC Palliative Care 2006, 5:4 http://www.biomedcentral.com/1472-684X/5/4
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tion of elderly (≥ 75 years) patients in the program has
increased over time from 28% (1993–1994) to 37% in the
current study years (1998–2002), PCP involvement
among patients less than 65 years of age remains relatively
higher given that among all cancer deaths in Nova Scotia,
46% are among those 75 years or older and only 26% less
than 65 years of age [8]. Possible under representation of
the elderly in a PCP program has been reported by others
and in our previous work [3,4,16]. This continues to raise
concerns for us about where the elderly access specialized
palliative care. Do they obtain palliative care from other
ambulatory or home based care programs of long term
care or other facilities or are they not getting the services
they need [17]?
Limitations
One of the major limitations to this study is the potential
loss of transition information when a patient is no longer
actively followed by the program. This may occur if a
patient changes residence and no longer resides in the
region served by the QEII PCP, their health had improved
such that they are no longer considered palliative or they
had a change in their personal caregiver. To complicate
the problem, patients may return to the program at any
point during their end of life. For all patients our database
retains a record of their admission, death date and transi-
tions made while in the program. It is therefore probable
that inclusion of patients while not being actively fol-
lowed for even a short period of time, could result in a
conservative underestimation of the number of transi-
tions made. Unfortunately, demographic information
collected is somewhat limited. It would be helpful to have
a much better description of the available supports to
patients in the community such as whether a caregiver
lives in the home, is available 24 hours a day, how many
caregivers are available, what private insurance is availa-
ble, etc. Having better measures of symptom severity
would permit a more thorough analysis of the specific
nature of symptoms that are associated with a greater
number of transitions. To further pursue the study of fac-
tors associated with transitions during the end of life it
may be necessary to design a study where additional infor-
mation is collected prospectively.
Conclusion
Many patients experience transitions or changes in loca-
tion or care at the end of life. Our data suggest there is
some variation in the number of these transitions associ-
ated with the demographics and diagnoses of patients. A
number of issues need further exploration such as the
associations with gender and age and how caregiver sup-
ports and symptom issues contribute to these. Also
important is the need to facilitate continuity of care across
settings since many transitions are inevitable and often
integral to care.
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